Logo
  • About
  • Contact
  • (888) 441-8033

Proprietary phage and endolysin platform targets Implant Infections, Bacterial Vaginosis and UTI

Proprietary discovery and engineering platform to develop precision phage therapies First phage candidate expected to enter the clinic in 2022 Pipeline of antimicrobial-resistance and microbiome applications Estimated $12 Billion addressable market for multi-drug resistant in...

View full release

December National Poll: Biden and Sanders Pull Away from the Pack as Warren Falls

In the latest Emerson College/WHDH National Poll of the Democratic Primary, former Vice President Joe Biden leads at 32%, followed by Senator Bernie Sanders at 25%. Senator Elizabeth Warren comes in third at 12%, followed by Mayor Pete Buttigieg at 8%, and entrepreneur Andrew ...

View full release

ABIMMUNE BIOPHARMA TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO

Dec. 17th 2019 -- Abimmune BioPharma today announced that it has scheduled a company presentation at Biotech Showcase™ 2020 to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Flora Fang, MD., PhD, the company Founde...

View full release

GaN Systems and SPARX advance GaN in Electric Vehicles

OTTAWA, Ontario, December 17, 2019 – GaN Systems today announces that SPARX Group "Mirai Creation Fund II (“Mirai fund”)" has made an investment in GaN Systems. Mirai fund provides capital to companies with the goal of accelerating innovation, Vehicle Electrification being one...

View full release

HOTELSBYDAY ACQUIRES HOTEL-AMENITY STARTUP DAYAXE IN PIVOTAL HOSPITALITY INDUSTRY DEAL

New York, NY, December 18, 2019 – HotelsByDay, the North-American provider of flexible daytime hotel rooms has announced the acquisition of Dayaxe, a startup that sells access to hotel amenities such as pool passes, cabanas, spas and fitness rooms.  “This acquisition creates t...

View full release

PHANES THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO

San Diego, CA -- January 7, 2020 –- Phanes Therapeutics, Inc., an emerging biotech company focused on innovative drug discovery in immuno-oncology, today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most...

View full release

Key Opinion Leader (KOL) Call on Epigenetics

The call featured a presentation and discussion by Key Opinion Leaders (KOLs) Damen Reed, MD (Moffitt Cancer Center) and Jonathan Whetstine, PhD (Fox Chase Cancer Center) who discussed Epigenetics, and how drugs that require gene expression ("epigenetics drugs") are a viable s...

View full release

NFL Alumni Adds Two Members to New Business Strategy Committee

National Football League Alumni (NFLA) is pleased to announce that two outstanding corporate professionals have joined the NFLA’s new Business Strategy Committee to help the organization better execute its dual mission to improve the lives of former NFL players and care for di...

View full release

The Novel Coronavirus 2019-nCoV and ARDS is Emerging as a One-Two Threat

In December 2019, a novel coronavirus COVID-19 was found to produce clusters of acute respiratory illness in Wuhan, China, now known as novel coronavirus–infected pneumonia (NCIP).  Deaths due to COVID-19 infection primarily occur in patients transferred to the ICU with NCIP. ...

View full release

Ceres Holographics Awarded Horizon 2020 Funding to Accelerate Commercialization of Holographic Technology for Next-Generation Displays

ST ANDREWS, Scotland, UK – December 11, 2019 - Ceres Holographics, an innovative developer of thin-film Holographic Optical Elements (HOEs) for next-generation transparent display (TD) and augmented reality heads-up-display (AR-HUD) solutions today announced reaching a key fun...

View full release
  • « First
  • ‹ Prev
  • …
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy